Record overview
Status and phase
Status: WITHDRAWN
Phase: PHASE2
Sponsor: Gilead Sciences
Condition: Metastatic Colorectal Cancer
NCT01915472
A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No participants enrolled